Orexo To Acquire Biolipox - Building A Specialty Pharma Company Driven By Innovation
November 10th, 2007
Orexo AB (STO:ORX) and the principal owners of Biolipox AB have reached an agreement under which Orexo will acquire Biolipox, an innovative Swedish research-based pharmaceutical company that develops new therapies for inflammatory diseases, including pain management and respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). [click link for full article]
